Merit Medical Systems, Inc., commonly referred to as Merit Medical, is a leading global provider of medical devices headquartered in the United States. Founded in 1987, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in interventional medicine, Merit Medical focuses on areas such as cardiology, radiology, and pain management. The company is renowned for its innovative core products, including catheter systems, access devices, and fluid management solutions, which are designed to enhance patient outcomes and streamline clinical procedures. Merit Medical's commitment to quality and innovation has positioned it as a trusted partner in the healthcare industry, with notable achievements in expanding its product portfolio and global reach.
How does Merit Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merit Medical's score of 43 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Merit Medical reported total carbon emissions of approximately 18,359,000 kg CO2e, with Scope 1 emissions at about 2,875,000 kg CO2e and Scope 2 emissions at around 15,476,000 kg CO2e. This marks an increase from 2023, when total emissions were approximately 17,656,000 kg CO2e, comprising about 3,072,000 kg CO2e in Scope 1 and about 14,584,000 kg CO2e in Scope 2. Notably, there were no reported Scope 3 emissions in 2023 or 2024. Merit Medical has not set specific reduction targets or initiatives as part of its climate commitments, and there are no emissions data cascaded from a parent company. The company continues to monitor its emissions and is committed to sustainability practices within the medical device industry.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 3,017,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 
| Scope 2 | 17,353,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | - | - | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merit Medical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
